[Skip to Content]
[Skip to Content Landing]
June 21, 1965

Need for Tuberculosis (BCG) Vaccination in the US

Author Affiliations

Commissioner of Health New York

JAMA. 1965;192(12):1106. doi:10.1001/jama.1965.03080250084032

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The recent fact sheet on tuberculosis vaccine (BCG) distributed to editors and science writers by the American Medical Association in trying to present a comprehensive picture of tuberculosis vaccination has given a misleading impression of its place in the tuberculosis control program in this country today. In recent years, tuberculosis has become increasingly concentrated in large cities and in poorer sections of these cities. Tuberculous infection occurs at an early age in a high proportion of adolescents and young adults and is frequently followed by the development of clinical disease. The traditional control methods of casefinding, treatment, and contact supervision have not been effective in preventing this. The only additional p-eventive measures available to these groups at this time are the widespread use of tuberculosis vaccine or isoniazid prophylaxis. The implication that tuberculosis vaccine is not needed where adequate tuberculosis control programs exist fails to give consideration

First Page Preview View Large
First page PDF preview
First page PDF preview